1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
C25H28FN5O3 — CID 139571031
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one (PubChem CID 139571031) has the molecular formula C25H28FN5O3 and a molecular weight of 465.53 g/mol. Its IUPAC name is 1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one.
Molecular Properties
| Compound Name | 1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one |
|---|---|
| PubChem CID | 139571031 |
| Molecular Formula | C25H28FN5O3 |
| Molecular Weight | 465.53 g/mol |
| Exact Mass | 465.22 |
| IUPAC Name | 1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one |
| SMILES | CN1Cc2c(-c3c(F)ccc4cc(N5CCOCC5)ncc34)nc(C3CCOCC3)n2CC1=O |
| InChI | InChI=1S/C25H28FN5O3/c1-29-14-20-24(28-25(31(20)15-22(29)32)16-4-8-33-9-5-16)23-18-13-27-21(30-6-10-34-11-7-30)12-17(18)2-3-19(23)26/h2-3,12-13,16H,4-11,14-15H2,1H3 |
| InChIKey | VEYLNCUMVWIALX-UHFFFAOYSA-N |
| XLogP | 2.94 |
| TPSA | 72.72 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.53 |
| LogP ≤ 5 | 2.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139571031 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.